Phase I/II Study of FR104 First Administration In Patient With Renal Transplantation: FIRsT Study

NCT04837092 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplantation

Interventions

DRUG: FR104

Sponsor

Nantes University Hospital

Collaborators

[object Object]